WW INTERNATIONAL INC
For the period ended Dec 30, 2023. Filed Feb 28, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 28, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Summary of Material Risks
A summary of the principal factors that create risk in investing in our securities and might cause actual results to differ from expectations is set forth below:
competition from other weight management and health and wellness industry participants or the development of more effective or more favorably perceived weight management methods;
our failure to continue to retain and grow our subscriber base;
our ability to be a leader in the rapidly evolving and increasingly competitive clinical weight management and weight loss market;
our ability to continue to develop new, innovative services and products and enhance our existing services and products or the failure of our services, products or brands to continue to appeal to the market, or our ability to successfully expand into new channels of distribution or respond to consumer trends or sentiment;
our ability to successfully implement strategic initiatives;
our ability to evolve our community offerings to meet the evolving tastes and preferences of our members;
the effectiveness and efficiency of our advertising and marketing programs, including the strength of our social media presence;
the impact on our reputation of actions taken by our franchisees, licensees, suppliers, affiliated provider entities, PCs’ healthcare professionals, and other partners, including as a result of our acquisition of Weekend Health, Inc., doing business as Sequence (“Sequence”) (the “Acquisition”);
the recognition of asset impairment charges;
the loss of key personnel, strategic partners or consultants or failure to effectively manage and motivate our workforce;
our ability to successfully make acquisitions or enter into collaborations or joint ventures, including our ability to successfully integrate, operate or realize the anticipated benefits of such businesses, including with respect to Sequence;
uncertainties related to a downturn in general economic conditions or consumer confidence, including as a result of the existing inflationary environment, rising interest rates, the potential impact of political and social unrest and increased volatility in the credit and capital markets;
the seasonal nature of our business;
our failure to maintain effective internal control over financial reporting;
the impact of events that impede accessing resources or discourage or impede people from gathering with others;
the early termination by us of leases;
the inability to renew certain of our licenses, or the inability to do so on terms that are favorable to us;
the impact of our substantial amount of debt, debt service obligations and debt covenants, and our exposure to variable rate indebtedness;
the ability to generate sufficient cash to service our debt and satisfy our other liquidity requirements;
uncertainties regarding the satisfactory operation of our technology or systems;
the impact of data security breaches and other malicious acts or privacy concerns, including the costs of compliance with evolving privacy laws and regulations;
our ability to successfully integrate and use artificial intelligence in our business;
our ability to enforce our intellectual property rights both domestically and internationally, as well as the impact of our involvement in any claims related to intellectual property rights;
risks and uncertainties associated with our international operations, including regulatory, economic, political, social, intellectual property, and foreign currency risks, which risks may be exacerbated as a result of war and terrorism;
the outcomes of litigation or regulatory actions;
the impact of existing and future laws and regulations;
risks related to the Acquisition, including risks that the Acquisition may not achieve its intended results;
risks related to our exposure to extensive and complex healthcare laws and regulations as a result of the Acquisition; and
other risks and uncertainties, including those detailed from time to time in our periodic reports filed with the Securities and Exchange Commission (the “SEC”).
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.